12:00 AM
Sep 01, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Aurograb: Phase II data

A Phase II trial to treat deep-seated S. aureus infection showed that IV Aurograb twice-daily plus vancomycin for 7 days showed a “lack of efficacy” compared...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >